The Systemic Picture

This section explores emerging approaches to controlling Lyme disease at population and systemic levels, including genetic technologies designed to reduce disease vectors, advances in diagnostic methods, and treatment research aimed at addressing current clinical limitations.

In this section

  • Vaccines

  • Gene Drives — Gene drives are genetic elements designed to copy themselves through populations faster than normal inheritance allows, potentially altering or suppressing wild populations of disease vectors like ticks. This section explores how gene drives work, how they might be applied to tick control, the current state of tick-specific research, concerns about their release, and containment strategies researchers have proposed.

  • Diagnostics and Treatment Research — This section explores current approaches to diagnosing and treating Lyme disease, examining why existing tests have limitations and what new diagnostic technologies are in development. It covers emerging methods including improved serology, direct detection, and biomarker panels, as well as the regulatory and funding challenges affecting their advancement.

  • The Human Cost — the emotional and patient-advocacy dimension; why the failures described here make people furious; this article is analytical, not emotional

  • Jurisdictions — descriptive guide to what organizations exist and how they operate; this article critiques the system, Section 9 describes it

  • After Infection — the patient experience of navigating the broken medical system: finding doctors who believe them, managing misdiagnosis, living with chronic illness; this article explains why the system fails analytically, not how individual patients cope with it

    Not medical advice. See a healthcare provider for medical decisions. Medical Disclaimer